What are the predictors of Fabry’s disease progression despite enzyme therapy?
Heart Podcast
00:00
Understanding Fabry's Disease and Its Impact on Heart Health
This chapter explores Fabry's disease, an X-linked lysosomal disorder caused by a deficiency in the alpha-galactosidase enzyme. It emphasizes the significance of early diagnosis, its systemic impacts, particularly on heart health, and discusses recent advancements in recombinant enzyme therapies for treatment.
Play episode from 01:48
Transcript
